期刊文献+

D-二聚体胶体金免疫层析法定量检测试剂盒性能评价 被引量:2

Performance Evaluation of D-dimer Colloidal Gold Immunochromatography Quantitative Detection Kit
下载PDF
导出
摘要 目的:评价采用胶体金免疫层析法自主研制的一种D-二聚体定量检测试剂盒的方法学性能。方法:检测试剂盒的检测限、线性范围、准确度、批内精密度、抗干扰性,并评价其与对比试剂的相关性。结果:本试剂盒检测限不高于0.1μg/mL;线性范围为0.2~5.0μg/mL,线性相关性为0.99;准确度小于15%;批内精密度小于10%;当样本中胆红素<200 mg/L,胆固醇<2500 mg/L,抗坏血酸<2500 mg/L时,对本试剂盒的检测无显著影响。用227人份的标本进行比对分析,显示本试剂盒与参比试剂盒检测相关性良好(R=0.994)。结论:本试剂盒属于床边检验(POCT),其线性范围宽,检测限、精密度、准确性、抗干扰性、比对相关性均能满足临床检测需要。 Object:To evaluate the quality and performance of the newly self-developed D-Dimer test kit which is established by Colloidal Gold Immunochromatography.Methods:Determine the limitation of detection,the linear range,accuracy,precision and the anti-inference ability of this kit as well as its correlation with contrast agents.Results:The limitation of detection is less than 0.1μg/mL,the linear ranges of the product are 0.2~5.0μg/mL and the correlation coefficient is 0.99.The precisions are less than 15%and the variations of accuracy fall within 10%.And there is no significant effect found when the concentration of bilirubin in the sample is less than 200 mg/L,cholesterol less than 2500 mg/L and the ascorbic acid less than 2500 mg/L.Additionally,a very good correlation(R=0.994)with Nanjing Jidan product is found by testing 227 human samples.Conclusion:This kit belongs to point-of-care testing product.The results of the linear range,the limitation of detection,precision,accuracy,anti-interference,correlation show that our D-Dimer test kit can be used in clinical diagnosis.
作者 王晓丽 李林 WANG Xiaoli;LI Lin(Shanghai Chemtron Biotech Co.,Ltd.,Shanghai 201318)
出处 《生物化工》 2021年第3期18-21,25,共5页 Biological Chemical Engineering
关键词 D-二聚体 胶体金免疫层析法 性能评价 D-Dimer Colloidal Gold Immunochromatography performance evaluation
  • 相关文献

参考文献4

二级参考文献33

  • 1[1]Rylatt DB,Blake AS,Cottis LE,et a1.An immunoassay for human D-dimer using monoclonal antibodies.Thromb Res,1983,31(6):767-771.
  • 2[2]Mauriello A.Sangiorgi G,Palnfieri G.et a1.Hyperfibrinogenemia is associated with specific histocytological composition and complications of arherosclerotic carotid plaques in patients affected by transientis chemic attacks.Circulation,2000,101(7):7443.
  • 3[4]Koyama T,Kakidhita E,Nakai Y,et a1.Significance of hemostatic molecular makers during disseminated intravascular coagulation in patients with liver treated by endoscopi cemtoolization for esophagealvatices.Am J Hemato1,1991,38:90.
  • 4BounameauxH,deMoerlooseP,ReberG,etal.D-dimertestinginsuspectedvenousthromboembolism:Anupdate[J].QJMED,1997,90:437.
  • 5WellsPS,HirshJ,AndersonDR,etal.Comparisonofaccuracyofimpedanceplethysmographyandcompressionultrasonographyinoutpatientswithclinicallysuspecteddeepveinthrombosis[J].ThrombHaemostas,1995,74:1423.
  • 6TukstraF,vanBeekEJR,tenCateJW,etal.Reliablerapidbloodtestfortheexclusionofvenousthromboembolinsminsymptomaticoutpatients[J].ThrombHaemostas,1996,76:9.
  • 7WellsPS,BrillEdwardsP,StevensP,etal.AnovelandrapidwholebloodassayforD-dimerinpatientswithclinicallysuspecteddeepveinthrombosis[J].Circulation,1995,91:2184.
  • 8FreyburgeG,TrillaudH,LabroucheS,etal.D-dimerstrategyinthrombosisexclusion-agoldstandardstudyin100patientssuspectedofdeepveinthrombosisorpulmonaryembollism:8DDmethodscompared[J].Thrombhaemostas,1998,79(1):32.
  • 9JanssenMCH,HeebelsAE,deMetzM,etal.ReliabilityoffiverapidD-DimerassayscomparedtoELISAintheexclusionofdeepvenousthrombosis[J].ThrombHaemostas,1997,77:262.
  • 10D'AngeloA,D'AlessandroG,Tomassini,etal.EvaluationofanewrapidquantitativeD-dimerassayinpatientswithclinicallysuspecteddeepveinthrombosis[J].ThrombHaemostas,1996,75:412.

共引文献216

同被引文献42

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部